A new COVID-19 variant, PJ.2.1, is drawing attention as it spreads across several countries, raising concerns about another seasonal rise in infections. First identified in Ontario, Canada, in May 2026, the variant has since been detected in parts of North America, Europe and Asia.
Early laboratory findings suggest that it may bind more efficiently to human cells, but researchers have not found evidence that it causes more severe illness or substantially escapes vaccine-induced immunity.